• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎相关肝细胞癌的多中心发生
World J Hepatol. 2011 Jan 27;3(1):15-23. doi: 10.4254/wjh.v3.i1.15.
2
Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients.同步多结节肝细胞癌患者多中心发生及肝内转移的临床病理特征与预后
Asian Pac J Cancer Prev. 2013;14(1):217-23. doi: 10.7314/apjcp.2013.14.1.217.
3
Multicentric occurrence of hepatocellular carcinoma: diagnosis and clinical significance.肝细胞癌的多中心发生:诊断及临床意义
J Hepatobiliary Pancreat Surg. 2001;8(5):435-40. doi: 10.1007/s005340100006.
4
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.非肝硬化非酒精性脂肪性肝病和代谢综合征背景下的肝细胞癌:美国的经验
Dig Dis Sci. 2015 Oct;60(10):3142-8. doi: 10.1007/s10620-015-3821-7. Epub 2015 Aug 7.
5
Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.伴有非酒精性脂肪性肝病/非酒精性脂肪性肝炎的丙型肝炎病毒相关肝硬化中的肝细胞癌的特殊组织学变异型:脂肪性肝炎相关肝细胞癌。
Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.
6
Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.非酒精性脂肪性肝炎相关肝细胞癌:我们的病例系列及文献复习。
World J Gastroenterol. 2010 Mar 28;16(12):1436-41. doi: 10.3748/wjg.v16.i12.1436.
7
Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.非酒精性脂肪性肝炎与酒精相关肝细胞癌的比较。
Clin Mol Hepatol. 2020 Apr;26(2):196-208. doi: 10.3350/cmh.2019.0012. Epub 2020 Jan 9.
8
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎相关肝细胞癌
Pathol Int. 2001 Feb;51(2):127-31. doi: 10.1046/j.1440-1827.2001.01174.x.
9
Hepatocellular carcinoma with nonalcoholic steatohepatitis.伴有非酒精性脂肪性肝炎的肝细胞癌
J Gastroenterol. 2004;39(4):391-6. doi: 10.1007/s00535-003-1308-3.
10
Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.肝细胞癌患者与酒精性肝病和非酒精性脂肪性肝炎患者的比较。
Alcohol Clin Exp Res. 2004 Aug;28(8 Suppl Proceedings):164S-168S. doi: 10.1097/01.alc.0000133547.70803.83.

引用本文的文献

1
Screening and follow-up of chronic liver diseases with understanding their etiology in clinics and hospitals.在诊所和医院对慢性肝病进行筛查、随访并了解其病因。
JGH Open. 2020 Aug 24;4(5):827-837. doi: 10.1002/jgh3.12406. eCollection 2020 Oct.
2
High alanine aminotransferase level as a predictor for the incidence of macrovascular disease in type 2 diabetic patients with fatty liver disease.高丙氨酸氨基转移酶水平作为2型糖尿病合并脂肪肝患者大血管疾病发生率的预测指标。
Hepatol Int. 2013 Jun;7(2):555-61. doi: 10.1007/s12072-012-9366-3. Epub 2012 Apr 5.
3
Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?与肝脂肪变性密切相关的内脏脂肪是否应该减少以提高生存率?
Hepatol Int. 2013 Jun;7(2):413-28. doi: 10.1007/s12072-012-9406-z. Epub 2012 Oct 26.
4
Exposure to ambient air particulate matter and non-alcoholic fatty liver disease.暴露于环境空气中的颗粒物与非酒精性脂肪性肝病。
World J Gastroenterol. 2013 Jul 7;19(25):3951-6. doi: 10.3748/wjg.v19.i25.3951.
5
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.基于系统综述的非酒精性脂肪性肝病与肝细胞癌风险的相关性。
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2. doi: 10.1016/j.cgh.2012.10.001. Epub 2012 Oct 4.

本文引用的文献

1
Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C.非酒精性脂肪性肝炎相关肝细胞癌与慢性丙型肝炎相关肝细胞癌的前瞻性研究。
J Gastroenterol. 2010 Sep;45(9):960-7. doi: 10.1007/s00535-010-0237-1. Epub 2010 Apr 8.
2
Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.非酒精性脂肪性肝炎相关肝细胞癌:我们的病例系列及文献复习。
World J Gastroenterol. 2010 Mar 28;16(12):1436-41. doi: 10.3748/wjg.v16.i12.1436.
3
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?非酒精性脂肪性肝炎相关肝细胞癌在肝硬化和非肝硬化患者中是否存在?
Braz J Med Biol Res. 2009 Oct;42(10):958-62. doi: 10.1590/s0100-879x2009005000019. Epub 2009 Sep 4.
4
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis.非酒精性脂肪性肝炎相关非肝硬化肝细胞癌。
J Gastroenterol. 2009;44(12):1190-4. doi: 10.1007/s00535-009-0112-0.
5
Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.非酒精性脂肪性肝炎相关肝细胞癌患者的肝移植
Clin Gastroenterol Hepatol. 2009 Jul;7(7):800-6. doi: 10.1016/j.cgh.2009.02.025. Epub 2009 Mar 9.
6
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者的肝细胞癌
J Gastroenterol. 2009;44 Suppl 19:89-95. doi: 10.1007/s00535-008-2262-x. Epub 2009 Jan 16.
7
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.非酒精性脂肪性肝炎所致肝硬化与慢性丙型肝炎所致肝硬化的临床特征及转归比较
J Gastroenterol Hepatol. 2009 Feb;24(2):248-54. doi: 10.1111/j.1440-1746.2008.05640.x. Epub 2008 Nov 20.
8
Surgically resected hepatocellular carcinomas in patients with non-alcoholic steatohepatitis.非酒精性脂肪性肝炎患者手术切除的肝细胞癌
Hepatogastroenterology. 2008 Jul-Aug;55(85):1404-6.
9
Primary liver cancers with nonalcoholic steatohepatitis.伴有非酒精性脂肪性肝炎的原发性肝癌
Eur J Gastroenterol Hepatol. 2007 Oct;19(10):827-34. doi: 10.1097/MEG.0b013e3282748ef2.
10
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.肝细胞癌的分期:对日本13772例患者队列中日本TNM和AJCC/UICC TNM系统的评估
Ann Surg. 2007 Jun;245(6):909-22. doi: 10.1097/01.sla.0000254368.65878.da.

非酒精性脂肪性肝炎相关肝细胞癌的多中心发生

Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis.

作者信息

Kawai Hirokazu, Nomoto Minoru, Suda Takeshi, Kamimura Kenya, Tsuchiya Atsunori, Tamura Yasushi, Yano Masahiko, Takamura Masaaki, Igarashi Masato, Wakai Toshifumi, Yamagiwa Satoshi, Matsuda Yasunobu, Ohkoshi Shogo, Kurosaki Isao, Shirai Yoshio, Okada Masahiko, Aoyagi Yutaka

机构信息

Hirokazu Kawai, Department of Clinical Laboratory, Niigata University Medical and Dental Hospital, Niigata 951-8510, Japan.

出版信息

World J Hepatol. 2011 Jan 27;3(1):15-23. doi: 10.4254/wjh.v3.i1.15.

DOI:10.4254/wjh.v3.i1.15
PMID:21307983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3035698/
Abstract

AIM

To reveal the manner of hepatocellular carcinoma (HCC) development in patients with nonalcoholic steatohepatitis (NASH) focusing on multicentric occurrence (MO) of HCC.

METHODS

We compared clinicopathological characteristics between patients with and without MO of HCC arising from NASH background. The clinical features were implicated with reference to the literature available.

RESULTS

MO of HCC was identified with histological proof in 4 out of 12 patients with NASH-related HCC (2 males and 2 females). One patient had synchronous MO; an advanced HCC, two well-differentiated HCCs and a dysplastic nodule, followed by the development of metachronous MO of HCC. The other three patients had multiple advanced HCCs accompanied by a well-differentiated HCC or a dysplastic nodule. Of these three patients, one had synchronous MO, one had metachronous MO and the other had both synchronous and metachronous MO. There were no obvious differences between the patients with or without MO in terms of liver function tests, tumor markers and anatomical extent of HCC. On the other hand, all four patients with MO of HCC were older than 70 years old and had the comorbidities of obesity, type 2 diabetes mellitus (T2DM), hypertension and cirrhosis. Although these conditions were not limited to MO of HCC, all the conditions were met in only one of eight patients without MO of HCC. Thus, concurrence of these conditions may be a predisposing situation to synchronous MO of HCC. In particular, old age, T2DM and cirrhosis were suggested to be prerequisite for MO because these factors were depicted in common among two other cases with MO of HCC under NASH in the literature.

CONCLUSION

The putative predisposing factors and necessary preconditions for synchronous MO of HCC in NASH were suggested in this study. Further investigations are required to clarify the accurate prevalence and predictors of MO to establish better strategies for treatment and prevention leading to the prognostic improvement in NASH.

摘要

目的

以肝细胞癌(HCC)的多中心发生(MO)为重点,揭示非酒精性脂肪性肝炎(NASH)患者中HCC的发展方式。

方法

我们比较了NASH背景下发生HCC的患者与未发生HCC的患者之间的临床病理特征。参考现有文献探讨了临床特征。

结果

12例NASH相关HCC患者中,4例经组织学证实存在HCC的MO(2例男性和2例女性)。1例患者为同步MO;1例进展期HCC、2例高分化HCC和1个发育异常结节,随后发生异时性HCC的MO。另外3例患者有多个进展期HCC,伴有1例高分化HCC或1个发育异常结节。这3例患者中,1例为同步MO,1例为异时性MO,另1例既有同步MO又有异时性MO。在肝功能检查、肿瘤标志物和HCC的解剖范围方面,有MO和无MO的患者之间没有明显差异。另一方面,所有4例有HCC的MO的患者年龄均超过70岁,并有肥胖、2型糖尿病(T2DM)、高血压和肝硬化的合并症。虽然这些情况并不局限于HCC的MO,但8例无HCC的MO的患者中只有1例同时具备所有这些情况。因此,这些情况的同时出现可能是HCC同步MO的易感情况。特别是,高龄、T2DM和肝硬化被认为是MO的先决条件,因为在文献中另外2例NASH下有HCC的MO的病例中也共同出现了这些因素。

结论

本研究提出了NASH中HCC同步MO的假定易感因素和必要前提条件。需要进一步研究以明确MO的准确患病率和预测因素,从而制定更好的治疗和预防策略,改善NASH的预后。